IP Library Granted Patent US 9,433,574
Granted Patent B2
US 9,433,574 · App. 14/727,638 · Granted Sep 6, 2016

Microfabricated nanopore device for sustained release of therapeutic agent

Inventors: Francis J. Martin (San Francisco, CA); Anthony A. Boiarski (Hillard, OH)
Assignee: Delpor, Inc.
A61K9/0004A61K9/0024A61K9/0097A61K9/1694A61K9/4808A61K38/02A61K38/19A61K38/27A61M5/14276A61M5/16804A61M31/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,433,574
App. No.
14/727,638
Granted
Sep 6, 2016
Kind
B2
Abstract

A drug delivery device that includes a capsule for implantation into the body; the capsule further includes a reservoir for containing a substance such as a therapeutic agent, at least one port for allowing the substance to diffuse from or otherwise exit the reservoir, and a nanopore membrane in communication with the capsule at or near the exit port for controlling the rate of diffusion of the substance from the exit port. The device also includes an optional screen for providing structural stability to the nanopore membrane and for keeping the pores of the nanopore membrane clear. One embodiment of the drug delivery device includes an osmotic engine internal to the device for creating fluid flow through the device.

Claims (11)

1. A device, comprising:

a capsule comprising a fluid impermeable wall defining a reservoir that contains a therapeutic agent; said capsule further comprising an exit port in communication with the reservoir and a nanopore membrane in communication with the exit port, wherein said nanopore membrane comprises an array of annular pores, each pore in the array having a pore diameter of between about 2-100 nm, and wherein said therapeutic agent has a Stoke's diameter that is between about 1-5 times said pore diameter, wherein the device comprises an amount of therapeutic agent sufficient to provide release at a rate that approaches zero-order for a period of several weeks.

2. The device of claim 1 , wherein the therapeutic agent is dispersed within said reservoir as an aqueous solution or aqueous suspension.

3. The device of claim 1 , wherein the therapeutic agent is in dry form.

4. The device of claim 1 , wherein the therapeutic agent is a peptide.

5. The device of claim 1 , wherein the therapeutic agent is a protein.

6. The device of claim 5 , wherein the protein is growth hormone.

7. The device of claim 1 , wherein the capsule is manufactured from a material selected from the group consisting of titanium alloy, surgical grade stainless steel, and a polymeric material.

8. The device of claim 1 , wherein said capsule is substantially cylindrical in cross section.

9. The device of claim 1 , wherein said capsule further comprises a first end and a second end, said wall extending from the first end to the second end.

10. The device of claim 9 , wherein said capsule is tapered at the first and second ends.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2016
From: MARTIN, FRANCIS J.; BOIARSKI, ANTHONY A.
To: IMEDD, INC.
Reel/Frame 039470/0438 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2016
From: IMEDD, INC.
To: DELPOR, INC.
Reel/Frame 039470/0508 →
Continuity (7)
Division 14083220 · Nov 18, 2013
Continuation 13098067 · Apr 29, 2011
Continuation 11530729 · Sep 11, 2006
Continuation 10243787 · Sep 13, 2002
Provisional Application 60371290 · Apr 9, 2002
Provisional Application 60322160 · Sep 14, 2001
Related Publication 20150258018A1 · Sep 17, 2015